Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines
Universitätsmedizin Göttingen · University of Göttingen · +41 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,302
total citations
- FWCI
- 47.22
- Percentile
- 100%
- References
- 439
Citations per year
Authors
41Topics & keywords
Topics
Keywords
- Transcranial magnetic stimulation
- Intensity (physics)
- Medicine
- Stimulation
- Neuroscience
- Business
- Physical medicine and rehabilitation
- Psychology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BSBristol-Myers Squibb
- GGlaxoSmithKline
- SSanofi
- BBiogen
- NFNovartis Foundation
- TPTakeda Pharmaceutical Company
- NNovocure
- BBrainsWay
- NPNihon Pharmaceutical
- BIBoehringer Ingelheim Japan
- KPKyorin Pharmaceutical
- UOUniversity of Cambridge
- UOUniversity of Oxford
- MOMinistry of Education, Culture, Sports, Science and TechnologyAwards: 15H05881, 25293206, 22390181
- DDaiichi-Sankyo
- DSDainippon Sumitomo Pharma
- MOMinistry of Health, Labour and WelfareAwards: 15H05881, 22390181, 25293206
- EEisai
- KHKyowa Hakko Kirin
- APAstellas Pharma
- OPOtsuka Pharmaceutical
- AFAstellas Foundation for Research on Metabolic Disorders
- TPTeijin Pharma
- SServier
- NFNOVARTIS Foundation (Japan) for the Promotion of Science
- MTMitsubishi Tanabe Pharma Corporation
- FPFP Pharmaceutical Corporation
- HLH. Lundbeck A/S
- CCorTec
- NINational Institutes of HealthAwards: 1R01NS095123-01, 1R01MH111896-01, 1R01MH109289-01, 1R01NS101362-01, 1R01MH111896, 1R01NS101362
- AAllergan
- NPNovartis Pharma
- CPChugai Pharmaceutical
- BYBayer Yakuhin
- BVBayer Vital
- NINational Institute of Neurological Disorders and StrokeAwards: 1R01NS101362, 1R01MH111896
- JPJanssen Pharmaceuticals
- DSDaiichi Sankyo Europe